Verve Therapeutics
(NASDAQ:VERV)
Verve Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Verve Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$35.59
1.80[5.33%]
At close: Aug 12
$35.59
After Hours: 4:00PM EDT
Day High/Low33.53 - 36
52 Week High/Low10.7 - 39.9
Open / Close33.94 / 35.59
Float / Outstanding31.9M / 59.9M
Vol / Avg.836.1K / 1M
Mkt Cap2.1B
P/E5.46
50d Avg. Price21.5
Div / Yield-
Payout Ratio-
EPS-0.62
Total Float31.9M

Verve Therapeutics (NASDAQ:VERV), Quotes and News Summary

Verve Therapeutics (NASDAQ: VERV)

Day High/Low33.53 - 36
52 Week High/Low10.7 - 39.9
Open / Close33.94 / 35.59
Float / Outstanding31.9M / 59.9M
Vol / Avg.836.1K / 1M
Mkt Cap2.1B
P/E5.46
50d Avg. Price21.5
Div / Yield-
Payout Ratio-
EPS-0.62
Total Float31.9M
Sector: Health Care.Industry: Biotechnology
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Verve Therapeutics Questions & Answers

Q
How do I buy Verve Therapeutics (VERV) stock?
A

You can purchase shares of Verve Therapeutics (NASDAQ: VERV) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Verve Therapeutics's (VERV) competitors?
Q
What is the target price for Verve Therapeutics (VERV) stock?
A

The latest price target for Verve Therapeutics (NASDAQ: VERV) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting VERV to fall to within 12 months (a possible -88.76% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Verve Therapeutics (VERV)?
A

The stock price for Verve Therapeutics (NASDAQ: VERV) is $35.59 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Verve Therapeutics (VERV) pay a dividend?
A

The next Verve Therapeutics (VERV) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?
A

Verve Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Verve Therapeutics (VERV) going to split?
A

There is no upcoming split for Verve Therapeutics.

Q
What sector and industry does Verve Therapeutics (VERV) operate in?
A

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.